A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics, Pharmacodynamics, and Safety of Glyburide in Healthy Volunteers

Condition:   HealthyInterventions:   Drug: Glyburide;   Drug: Canagliflozin (JNJ-28431754)Sponsors:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.;   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Completed - verified December 2012
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials